Test |
Positive |
Negative |
|
|
|
|
Culture Positive |
Culture Negative |
Culture Positive |
Culture Negative |
k |
TLC |
08 |
08 |
05 |
29 |
0.40 |
ANC |
10 |
15 |
15 |
10 |
0.28 |
I:T Ratio |
13 |
12 |
00 |
25 |
0.52 |
Platelets |
02 |
09 |
11 |
28 |
0.00 |
Micro ESR |
07 |
08 |
06 |
29 |
0.30 |
CRP |
11 |
18 |
02 |
19 |
0.26 |
2 or more |
12 |
18 |
01 |
19 |
0.30 |
3 or more |
12 |
09 |
01 |
28 |
0.57 |
Test |
Total Positive |
Positive with Proven Sepsis |
Sn |
Sp |
PPV |
NPV |
LR |
TLC |
16 |
08 |
62 |
78 |
50 |
85 |
|
ANC |
25 |
10 |
77 |
59 |
40 |
88 |
|
I:T Ratio |
25 |
13 |
100 |
68 |
52 |
100 |
|
Platelets |
11 |
02 |
15 |
76 |
18 |
72 |
|
Micro ESR |
15 |
07 |
54 |
78 |
47 |
78 |
|
CRP |
29 |
11 |
85 |
51 |
38 |
90 |
|
2 or more
test positive |
30 |
12 |
92 |
51 |
40 |
95 |
|
3 or more test positive |
21 |
12 |
92 |
76 |
57 |
96.6 |
|
Combination of Parameters |
Total Positive |
Positive with Proven |
Sn |
Sp |
PPV |
NPV |
Two Test |
|
|
|
|
|
|
ANC + I:T Ratio |
17 |
10 |
77 |
81 |
59 |
91 |
TLC + PC |
3 |
2 |
15 |
97 |
67 |
77 |
I:T Ratio + CRP |
23 |
11 |
85 |
68 |
48 |
93 |
Three Test |
|
|
|
|
|
|
TLC+PC+ I:T Ratio |
3 |
2 |
15 |
97 |
66 |
77 |
ANC + I:T Ration + CRP |
15 |
11 |
85 |
89 |
73 |
94 |
I:T Ratio + Micro ESR+ CRP |
13 |
8 |
62 |
86 |
62 |
86 |
Four Test |
|
|
|
|
|
|
TLC+PC+CRP+ I:T Ratio |
3 |
2 |
15 |
97 |
66 |
77 |
Five Test |
|
|
|
|
|
|
TLC+ANC+ I:T Ratio + CRP+Micro ESR |
7 |
4 |
31 |
92 |
57 |
79 |
TLC+ANC+I:T Ratio+CRP+ Platelets |
2 |
1 |
08 |
97 |
50 |
75 |
All Six Test |
|
|
|
|
|
|
TLC+ANC+I:T Ratio +CRP+MicroESR+Platelet Count |
1 |
0 |
00 |
97 |
00 |
73 |
Authors (Year) |
SN% |
SP% |
PPV % |
NPV % |
Philip et al [6] |
50 |
94 |
40 |
- |
Rodwel et
al [16] |
44 |
92 |
36 |
94 |
Basu et al [18] |
12 |
93 |
50 |
32 |
Present Study |
62 |
78 |
50 |
85 |
Author (year) |
Sn(%) |
SPC% |
PPYC% |
NOVC |
Philipe et al [6] |
30 |
97 |
43 |
- |
Gerdes et al [5] |
31 |
94 |
24 |
95 |
Singh et al [7] |
55 |
81 |
- |
- |
Present study |
54 |
78 |
47 |
78 |
Author (year) |
Sn(%) |
SPC% |
PPYC% |
NOVC |
Phillipe et al [6] |
47 |
86 |
22 |
- |
Singh et al [7] |
80 |
91 |
- |
- |
Gerdes et al [5] |
93 |
85 |
28 |
99 |
Basu et at [18] |
92 |
68 |
92 |
86 |
Present study |
85 |
51 |
38 |
90 |